Cline Scientific
0.159 SEK +13.62%Be the first to follow this company
Cline Scientific develops cancer diagnostics and regenerative medicine treatments. The company is working with R&D through joint collaborations with pharmaceutical companies and academic researchers around the world. The patented surface nanotechnology is used in cell-based products and processes to drive projects within Life Science into and through the clinical phase. Cline operates out of Gothenburg, Sweden and was founded in 2012 from a long term research project in surface nanotechnology.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
CLINE B
Daily low / high price
0.159 / 0.159
SEK
Market cap
7.18M SEK
Turnover
95.1 SEK
Volume
600
Financial calendar
General meeting
2024-06-19
Interim report
2024-08-23
Annual report
2025-02-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Patrik Sundh | 19.4 % | 38.6 % |
Formu Consulting AB | 5.2 % | 11.4 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Cline Scientific lämnar uppdatering om bolagets finansiella ställning
BioStock: Vetenskaplig rådgivare om potentialen i Clines cellterapi mot broskskador
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools